Outcome of Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Post-Immune Checkpoint Inhibitor (ICI) Treatment

This study examines the efficacy of cetuximab as a subsequent treatment.

Source: International Journal of Radiation Oncology * Biology * Physics - March 14, 2024 Category: Radiology Authors: J.C. Park, R.D. Merkin, L. Wirth, M.J. Patel, T.J. Roberts Tags: 158 Source Type: research